Berenberg lowered the firm’s price target on Zealand Pharma (ZLDPF) to DKK 1,050 from DKK 1,080 and keeps a Buy rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZLDPF:
- Zealand Pharma’s Earnings Call: Clinical Gains and Challenges
- Zealand Pharma price target lowered to DKK 750 from DKK 755 at Morgan Stanley
- Zealand Pharma Reports Transformative Year with Strong R&D Focus
- ZLDPF Earnings this Week: How Will it Perform?
- Zealand Pharma initiated with an Equal Weight at Morgan Stanley